2m 2m 2m 2m 2m 2m 2m
Ingevity (NGVT)
NYSE
$72.66-$0.08 (-0.11%)
Price as of Jun 23, 2026 5:39 PM EDT- $2.5BMarket Cap
- 72.12%1-Year Change
- Specialty ChemicalsIndustry
Ingevity (NGVT)
$72.66-$0.08 (-0.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B -16.98% | 1.4B -16.88% | 1.7B +1.43% | 1.7B +19.89% | |
Cost of Revenue | 706.1M -25.81% | 951.7M -22.00% | 1.2B +11.11% | 1.1B +24.98% | |
Gross Profit | 461.5M +1.50% | 454.7M -3.64% | 471.9M -17.23% | 570.1M +11.17% | |
Sales and Marketing Expense | 171.2M +2.70% | 166.7M -9.25% | 183.7M -7.60% | 198.8M +10.88% | |
Research and Development Expense | -28.4M +1.07% | -28.1M -11.64% | -31.8M +4.95% | -30.3M +15.21% | |
Depreciation and Amortization Expense | 106.4M -1.75% | 108.3M -11.81% | 122.8M +12.87% | 108.8M -1.00% | |
Total Operating Expenses | 706.1M -25.81% | 951.7M -22.00% | 1.2B +11.11% | 1.1B +24.98% | |
Operating Profit | -142.1M -73.47% | -535.6M +5,202.97% | -10.1M -103.75% | 269.6M +65.60% | |
Interest Income | 5.2M -32.47% | 7.7M +22.22% | 6.3M -16.00% | 7.5M +87.50% | |
Interest Expense | -78.3M -19.94% | -97.8M +4.82% | -93.3M +50.97% | -61.8M +19.54% | |
Interest Income and Expense and Net | -73.1M -18.87% | -90.1M +3.56% | -87.0M +60.22% | -54.3M +13.84% | |
Total Nonoperating Income and Expense | -25.0M -85.28% | -169.8M +2,878.95% | -5.7M -435.29% | 1.7M +102.13% | |
Income before Taxes | -142.1M -73.47% | -535.6M +5,202.97% | -10.1M -103.75% | 269.6M +65.60% | |
Income Taxes | 8.2M +107.79% | -105.3M +2,140.43% | -4.7M -108.10% | 58.0M +29.75% | |
Extraordinary Items | 109.3M +721.80% | 13.3M 0.00% | 13.3M N/A | 0 N/A | |
Net Income | -167.1M -61.17% | -430.3M +7,868.52% | -5.4M -102.55% | 211.6M +79.17% | |
Net Income from Continuing Operations Applicable to Common | -150.3M -71.94% | -535.6M +5,202.97% | -10.1M -103.75% | 269.6M +65.60% | |
Basic EPS and Net Income | -4.61 -61.10% | -11.85 +7,800.00% | -0.15 -102.71% | 5.54 +86.53% | |
Diluted EPS and Net Income | -4.61 -61.10% | -11.85 +7,800.00% | -0.15 -102.73% | 5.50 +86.44% | |
Basic Weighted Average Shares | 36.2M -0.28% | 36.3M -0.47% | 36.5M -4.41% | 38.2M -4.11% | |
Diluted Weighted Average Shares | 36.2M -0.28% | 36.3M -0.47% | 36.5M -5.13% | 38.5M -3.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 78.1M +14.85% | 68.0M -29.09% | 95.9M +25.03% | 76.7M -72.15% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 78.1M +14.85% | 68.0M -29.09% | 95.9M +25.03% | 76.7M -72.15% | |
Total Current Assets | 454.2M -7.91% | 493.2M -25.11% | 658.6M -3.00% | 679.0M -6.33% | |
Accumulated Depreciation | 967.2M +1.08% | 956.9M +16.85% | 818.9M +15.21% | 710.8M +8.42% | |
Property and Plant and Equipment and Net | 608.1M -7.71% | 658.9M -13.55% | 762.2M -4.56% | 798.6M +10.96% | |
Total Long-Term Assets | 74.9M -5.55% | 79.3M -3.17% | 81.9M -4.21% | 85.5M -21.92% | |
Total Assets | 1.7B -18.37% | 2.0B -22.90% | 2.6B -4.14% | 2.7B +10.83% | |
Income Taxes Payable | 59.8M -3.24% | 61.8M -22.85% | 80.1M -27.25% | 110.1M -8.86% | |
Total Short-Term Debt | 47.1M -23.16% | 61.3M -27.37% | 84.4M +9,277.78% | 900,000 -95.41% | |
Total Current Liabilities | 341.3M +29.23% | 264.1M -27.23% | 362.9M +19.57% | 303.5M +12.87% | |
Total Long-Term Debt | 1.2B -13.31% | 1.3B -3.12% | 1.4B -6.09% | 1.5B +17.80% | |
Total Long-Term Liabilities | 40.5M -68.99% | 130.6M +3.08% | 126.7M +10.27% | 114.9M -8.45% | |
Total Liabilities | 1.6B -11.27% | 1.8B -8.26% | 2.0B -2.27% | 2.0B +13.54% | |
Retained Earnings | 404.9M -29.21% | 572.0M -42.93% | 1.0B -0.54% | 1.0B +26.58% | |
Total Stockholders Equity | 29.7M -84.78% | 195.2M -69.08% | 631.4M -9.58% | 698.3M +3.64% | |
Total Shares Outstanding | 35.5M -2.38% | 36.4M +0.32% | 36.2M -2.86% | 37.3M -5.02% | |
Cash Flow | |||||
Cash from Operating Activities | 331.2M +157.54% | 128.6M -37.30% | 205.1M -34.49% | 313.1M +6.86% | |
Capital Expenditures | 57.7M -25.64% | 77.6M -29.33% | 109.8M -22.95% | 142.5M +37.28% | |
Cash from Investing Activities | -57.5M -27.67% | -79.5M +2.85% | -77.3M -86.04% | -553.9M +293.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -252.2M +259.26% | -70.2M -29.73% | -99.9M -307.69% | 48.1M +136.14% | |
Financials Ratio | |||||
Gross Margin | 39.53% +22.25% | 32.33% +15.93% | 27.89% -18.39% | 34.17% -7.27% | |
Operating Margin | -12.17% -68.04% | -38.08% +6,280.13% | -0.60% -103.69% | 16.16% +38.13% | |
Return on Assets | -9.10% -50.89% | -18.52% +9,093.00% | -0.20% -102.48% | 8.13% +65.34% | |
Return on Equity | -148.60% +42.73% | -104.11% +12,718.67% | -0.81% -102.63% | 30.84% +71.83% | |
Revenue Growth | -16.98% +0.56% | -16.88% -1,283.53% | 1.43% -92.83% | 19.89% +37.92% | |
Current Ratio | 1.33 -28.74% | 1.87 +2.90% | 1.81 -18.88% | 2.24 -17.01% | |
Cash Ratio | 0.23 -11.15% | 0.26 -2.57% | 0.26 +4.59% | 0.25 -75.33% | |
Debt-to-Equity Ratio | 40.69 +466.93% | 7.18 +208.87% | 2.32 +10.13% | 2.11 +11.98% | |
Debt-to-Assets Ratio | 0.73 +5.66% | 0.69 +23.85% | 0.56 +3.88% | 0.54 +4.71% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow